Publications by authors named "Demarchi Martin"

Claim this Profile
I
Influence of pneumatic transportation on the stability of monoclonal antibodies.
Pierre Coliat, Stéphane Erb, Hélène Diemer, Dan Karouby, Tristan Martin, Martin Demarchi

Sci Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaplastic Lymphoma Kinase Inhibitor-Induced Neutropenia: A Systematic Review.
Fabien Moinard-Butot, Simon Nannini, Cathie Fischbach, Safa Abdallahoui, Martin Demarchi

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data on Newly Diagnosed -Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database.
Marta Bini, Stanislas Quesada, Pierre Meeus, Manuel Rodrigues, Eric Leblanc, Martin Demarchi

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients.
Brice Paquette, Elsa Kalbacher, Frédéric Mercier, Zaher Lakkis, Alexandre Doussot, Martin Demarchi

Ann Surg Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group.
Lise Lecointre, Virginie Bund, Eva Sangnier, Lobna Ouldamer, Sofiane Bendifallah, Martin Koskas, Martin Demarchi

Ann Surg Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase I study comparing the pharmacokinetics of a bevacizumab (HD204) biosimilar to European Union- and United States of America-sourced bevacizumab.
Martin Demarchi, Pierre Coliat, Philippe Barthelemy, Roland Schott, Meher BenAbdelghani

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
Hélène Carinato, Mickaël Burgy, Régine Ferry, Cathie Fischbach, Michal Kalish, Martin Demarchi

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TROIKA-1: A double-blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU-Herceptin and US-Herceptin in healthy male subjects.
Martin Demarchi, Pierre Coliat, Kristi Mclendon, Jocelyn Chung Shii Hii, Peggy Feyaerts

Pharmacol Res Perspect· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response analysis of Raltitrexed assessing liver toxicity.
Bernard Royer, Antonin Schmitt, Thierry Nguyen, Marie-Justine Paillard, Marine Jary, Martin Demarchi

Br J Clin Pharmacol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FDG PET/CT Imaging of Peritoneal Fibrosis Mimicking Persistent Metastatic Ovarian Carcinoma.
Benjamin Leroy-Freschini, Véronique Lindner, Thomas Boisramé, Martin Demarchi

Nucl Med Mol Imaging· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of Physical Status From Diagnosis to the End of First-Line Treatment in Breast, Lung, and Colorectal Cancer Patients: The PROTECT-01 Cohort Study Protocol.
Joris Mallard, Elyse Hucteau, Roland Schott, Thierry Petit, Martin Demarchi

Front Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN).
Virginie Bund, Lise Lecointre, Michel Velten, Lobna Ouldamer, Sofiane Bendifallah, Martin Koskas, Martin Demarchi

J Clin Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN).
Lise Lecointre, Michel Velten, Massimo Lodi, Ralph Saadeh, Vincent Lavoué, Martin Koskas, Demarchi Martin

Eur J Obstet Gynecol Reprod Biol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer.
Christian Borel, Olivier Regnier-Gavier, Hélène Carinato, Sébastien Guihard, Delphine Antoni, Martin Demarchi

Oncotarget· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prevalence and management of pain in patients with metastatic cancer in Franche-Comté].
Fanny Dénommé, Marie Kroemer, Philippe Montcuquet, Gilles Nallet, Antoine Thiery-Vuillemin, Martin Demarchi

Bull Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian Cancer.
Laura Mansi, Martin Demarchi, Fernando Bazan, Delphine Delroeux, Loïc Chaigneau

Int J Gynecol Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.
Frédéric Fiteni, Thierry Nguyen, Dewi Vernerey, Marie-Justine Paillard, Stefano Kim, Martin Demarchi

Cancer Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.
Frédéric Fiteni, Marine Jary, Franck Monnien, Thierry Nguyen, Eric Beohou, Martin Demarchi

BMC Gastroenterol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bifractionated CPT-11 with LV5FU2 infusion (FOLFIRI-3) in combination with bevacizumab: clinical outcomes in first-line metastatic colorectal cancers according to plasma angiopoietin-2 levels.
Stefano Kim, Erion Dobi, Marine Jary, Franck Monnien, Elsa Curtit, Martin Demarchi

BMC Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?
Erion Dobi, Fernando Bazan, Armelle Dufresne, Martin Demarchi, Cristian Villanueva

Int J Clin Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.
Erion Dobi, Franck Monnien, Stefano Kim, Arben Ivanaj, Thiery N'Guyen, Martin Demarchi

Clin Colorectal Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.
Elsa Curtit, Loïc Chaigneau, Julien Pauchot, Thierry Nguyen, Virginie Nerich, Martin Demarchi

Anticancer Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabazitaxel: a novel microtubule inhibitor.
Cristian Villanueva, Fernando Bazan, Stefano Kim, Martin Demarchi, Loïc Chaigneau

Drugs· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour.
Veronique Lorgis, Marie Paule Algros, Cristian Villanueva, Loic Chaigneau, Antoine Thierry-Vuillemin, Martin Demarchi

Breast· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors.
Antoine Thiery-Vuillemin, Erion Dobi, Thierry Nguyen, Bernard Royer, Damien Montange, Martin Demarchi

Anticancer Drugs· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis